Bamipine

DERMATOLOGICALS

Key facts

Bamipine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including HRH1. Recorded indications include Urticaria.

• Molecular targets: HRH1 (1 listed in DrugCentral).
• Indications: Urticaria.
• ATC code: D04AA15 (Antihistamines for topical use).
• Molecular formula: C19H24N2; molecular weight 280.42 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Urticaria

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Histamine H1 receptor	HRH1	antagonist	—

ATC classification

ATC code	Therapeutic hierarchy
D04AA15	DERMATOLOGICALS › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › Antihistamines for topical use
R06AX01	RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use

Chemical structure

• Molecular formula: C₁₉H₂₄N₂
• Molecular weight: 280.42 g/mol
• CAS number: 4945-47-5
• InChIKey: VZSXTYKGYWISGQ-UHFFFAOYSA-N
• PubChem CID: 72075

CN1CCC(CC1)N(CC1=CC=CC=C1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Bamipine used for?

DrugCentral lists the following indications for Bamipine: Urticaria.

How does Bamipine work?

Its molecular targets in DrugCentral include HRH1 (antagonist).

What is the chemical formula of Bamipine?

Bamipine has the molecular formula C19H24N2 and a molecular weight of 280.42 g/mol.

Sources

• DrugCentral drug card 288 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL520400 — compound record and bioactivity
• PubChem CID 72075 — chemical identifiers
• DrugBank DB13489 — drug record
• FDA UNII Y6BHZ28O92 — substance identity
• UniProt P35367 (HRH1) — target protein

How this page is built: methodology · editorial policy & corrections.